Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $11.79
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve analysts that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year target […]
More Stories
iShares MSCI Colombia ETF (NYSEARCA:ICOL) Stock Price Down 0.2% – Time to Sell?
iShares MSCI Colombia ETF (NYSEARCA:ICOL – Get Free Report) were down 0.2% during trading on Monday . The stock traded...
Pacer Data & Infrastructure Real Estate ETF (NYSEARCA:SRVR) Trading Up 0.1% – Still a Buy?
Pacer Data & Infrastructure Real Estate ETF (NYSEARCA:SRVR – Get Free Report) shares traded up 0.1% during mid-day trading on...
Arctic Star Exploration (CVE:ADD) Stock Price Down 33.3% – Time to Sell?
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shares dropped 33.3% on Monday . The company traded as low...
Dr. Hönle (ETR:HNL) Trading 0.3% Higher – Here’s Why
Dr. Hönle AG (ETR:HNL – Get Free Report)’s stock price rose 0.3% during mid-day trading on Monday . The company...
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) vs. 3M (NYSE:MMM) Head to Head Contrast
3M (NYSE:MMM – Get Free Report) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) are both multi-sector...
Boralex (OTCMKTS:BRLXF) Shares Down 1% – Here’s Why
Boralex Inc. (OTCMKTS:BRLXF – Get Free Report) traded down 1% on Monday . The company traded as low as $20.18...